Welcome
Greater Boston Interventional Neuropsychiatrist Michael Kritzer, MD, PhD
A Harvard-trained neuropsychiatrist providing comprehensive care
tailored for each patient
A Harvard-trained neuropsychiatrist providing comprehensive care
tailored for each patient
Behavioral Neurology and Neuropsychiatry at Massachusetts General Hospital, 2020
Psychiatry Residency, Duke University Medical Center, 2019
Doctor of Medicine, University of Miami Miller School of Medicine, 2015
Doctor of Philosophy, Molecular and Cellular Pharmacology,
University of Miami Miller School of Medicine, 2013
Harvard Medical School
Massachusetts General Hospital
Ketamine Clinic, Associate Director
Neuropsychiatry Outpatient Clinic
Transcranial Magnetic Stimulation Service
McLean Hospital
Rekindle Health,
Founding Medical Director
Augmend Health, Inc,
Scientific Advisory Board
Supported by federally-funded and institutional grants, I am engaged in clinical and preclinical research at Massachusetts General Hospital and McLean Hospital.
My research, in collaboration with esteemed investigators, focuses on several key projects:
MGH Ketamine Clinic
Optimizing clinical response to intravenous ketamine and intranasal esketamine
MGH Transcranial Magnetic Stimulation
Understanding predictors of treatment response
Laboratory of Joan Camprodon, MGH
Understanding neurocorrelations of depression and treatment with Ketamine and Electroconvulsive Therapy.
Laboratory of Kerry Ressler, McLean
Longitudinal assessment of rodent neurocircuits with functional and structural neuroimaging.
Publications:
Treatment Approach
I am a Harvard-trained interventional neuropsychiatrist board-certified in psychiatry through the American Board of Psychiatry and Neurology. After completing a fellowship in Behavioral Neurology and Neuropsychiatry at Massachusetts General Hospital, I am the Associate Director of the MGH Ketamine Clinic.
My additional roles at MGH include being an attending physician in the MGH outpatient Neuropsychiatry Clinic, the MGH Ketamine Clinic, the MGH Transcranial Magnetic Stimulation, and the founding medical director of Rekindle Health. My research focuses on translational neuroimaging to understand neurocircuit-based mechanisms of depression and its treatments.
My approach emphasizes providing evidence-based and neuroscientifically-informed treatment, allowing me to create thoughtful neuropsychiatric and neurocircuit-based formulations tailored to support each patient’s individual needs and goals. I am an expert in psychopharmacology, TMS, Spravato/Ketamine, and psychotherapy
Areas of Expertise
I have particular expertise in Ketamine, TMS, Long-haul Covid (Post-Acute Sequelae of Covid, PASC), as well as depression, anxiety, ADHD, PTSD, OCD, TBI, Tourette’s Syndrome, and tic-related disorders. Additionally, I address psychiatric challenges in patients with neurological disorders like multiple sclerosis, stroke, and neurodegenerative conditions including Parkinson's Disease and dementing illnesses.
Consultations
I offer specialized neuropsychiatry- and neuroscientifically-informed consultations for patients and organizations
Billing and Fees
Like most psychiatrists in the Boston area who practice outside hospital clinics, I do not participate in-network with any insurance companies. Accordingly, you will be responsible in full for your bill at the time of treatment. I accept payment by credit card or Zelle.
I am not taking new patients into my Neuropsychiatry practice; however, please feel free to reach out for a consultation.
Michael Kritzer, MD, PhD, is a Harvard-trained interventional neuropsychiatrist in Boston, Massachusetts.
Files coming soon.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.